The effects of dopamine receptor agonists on the levels of the striatal serotonin 5-HT,, receptor and its mRNA were investigated in rats lesioned with 6-OHDA as neonates. The mRNA encoding for the .5-HT,, receptor was detected by in situ hybridization histochemistry and the binding to 5HT,, receptors was revealed with ['251](2,5-dimethoxy-4-iodophenyl)2-aminopropane (['251]DOI). In adult control unlesioned rats, labeling with the 5-HT,, cRNA probe and with ['251]DOI was concentrated in medial sectors of the striatum. In 6-OHDAlesioned rats, labeling with the 5-HT,, cRNA probe or with ['251]DOI was increased in the striatum, particularly in its lateral subdivisions.
The effects of dopamine receptor agonists on the levels of the striatal serotonin 5-HT,, receptor and its mRNA were investigated in rats lesioned with 6-OHDA as neonates. The mRNA encoding for the .5-HT,, receptor was detected by in situ hybridization histochemistry and the binding to 5HT,, receptors was revealed with ['251 ](2,5-dimethoxy-4-iodophenyl)2-aminopropane (['251]DOI). In adult control unlesioned rats, labeling with the 5-HT,, cRNA probe and with ['251 ]DOI was concentrated in medial sectors of the striatum. In 6-OHDAlesioned rats, labeling with the 5-HT,, cRNA probe or with ['251 ]DOI was increased in the striatum, particularly in its lateral subdivisions.
These increases were abolished after chronic systemic administration of the dopamine receptor agonists apomorphine or SKF-38393. The mRNA levels encoding for the 5-HT,, receptor were further measured in individual striatal neurons after double-labeling of sections with a 5-HT,, and a preproenkephalin (PPE) cRNA probe. In control unlesioned rats, 5-HT,, mRNA labeling was distributed in PPE-labeled as well as in PPE-unlabeled striatal neurons. In 6-OHDA-lesioned rats, increased 5-HT,, mRNA labeling was found only in PPEunlabeled neurons and it was abolished after apomorphine or administration.
These results demonstrate that agonists of dopamine receptors inhibit the expression of 5-HT,, receptors in a subpopulation of presumed striato-nigral neurons. We propose that this regulation plays an important role in the control of motor activity by dopamine and 5-HT in the basal ganglia.
Key words: striatum; 5-HT; dopamine; 6-OHDA; 5-HT,, serotonin receptor; Dl dopamine receptor Dopamine and 5-HT play an important role in several brain functions. Altered regulation of these two nemotransmitters in the basal ganglia is associated with various behavioral dysfunctions including motor and obsessive-compulsive disorders (Sandyk et al., 1988) . The striatum, one of the major components of the basal ganglia, receives a dense dopaminergic input from the substantia nigra pars compacta as well as serotoninergic projections from the dorsal raphe nucleus. Serotoninergic and dopaminergic systems in the striatum interact with each other, and such interaction might play a key role in their respective modes of action. For instance, it has been demonstrated that 5-HT facilitates the release of dopamine in the striatum (Benloucif et al., 1993; Gallaway et al., 1993; Yadid et al., 1994; Bonhomme et al., 1995) and regulates the firing rate of dopamine neurons in the substantia nigra (Kelland et al., 1990) . Reciprocally, dopamine afferents are able to facilitate the release of 5-HT in the raphe dorsalis and, at the same time, inhibit this release in the striatum (Lee and Geyer, 1984; Ferre and Artigas, 1993; FerrC et al., 1994 ).
An interaction between dopaminergic and serotoninergic in- Recei ved Jan. 19, 1996; revised March 6, lYY6; accepted March 8, 1996 puts to the striatum is also evidenced in adult rats injected with 6-OHDA as neonates. These rats demonstrate an important decrease in the number of dopaminergic afferents and, at the same time, an increased density of 5-HT axons in the striatum, predominantly in its rostra1 half (Stachowiak et al., 1984; Berger et al., 1985; Snyder et al., 1986; Descarries et al., 1992) . The S-HT hyperinnervation is paralleled by an increase in striatal 5-HT content and reuptake (Luthman et al., 1987; Molina-Holgado et al., 1993 , 1994 . Neonatal 6-OHDA lesions also induce an increased ligand binding to striatal serotonin S- HT,,,, 5-HT,,,,,,,An, and 5-HT,, receptors (Radja et al., 1993) and an increased responsiveness of striatal neurons to iontophoretic application of 5-HT receptor agonists (El Mansari et al., 1994 ). An increase in 5-HT,,, but not 5-HT,, or 5-HT,,-(also called S-HT,(.), mRNA levels has also been recently reported in the striatum of rats injected with 6-OHDA as adults (Numan et al., 1995) .
Adult rats lesioned with 6-OHDA as neonates demonstrate supersensitive behavioral responses to the administration of dopamine Dl receptor agonists (Breese et al., 1985a,b) . In addition, the motor hyperactivity exhibited by these rats under drug-free conditions has been shown to involve 5-HT,, receptors (Luthman et al., 1991) . These data indicate that both the Dl and 5-HT,, receptor subtypes are preferentially involved in some of the motor abnormalities and adaptive changes exhibited by rats lesioned with 6-OHDA as neonates. In the present study, we tested the hypothesis that dopamine receptor agonists, particularly Dl agonists, are involved in the modulation of striatal 5-HT2, receptor levels in adult rats lesioned with 6-OHDA as neonates. Because striatal projection neurons can be distinguished as two subpopu-lations that either express or do not express the preproenkephalin (PPE) mRNA, we further analyzed the fate of the mRNA encoding for the SHT,, receptor in these two neuronal subpopulations. (1985) . Frozen sections (IO Fm thick) were dried under a flow of air and rinsed for 5 min at 4°C in 50 mM Tris butfer with 120 mM NaCl and 5 mM KCI to wash otf the endogenous l&and. They wcrc then incubated for 40 min in 15 nM ['Hlmazindol (DuPont NEN; specific activity, 22.7 Ciimmol) in 50 mM Tris buffer containing 300 mM NaCl and 5 mM KC]. Desipramine (0.3 pM) was added to the incubation medium to block the norepinephrine transporter.
MATERIALS AND METHODS
Sections were then rinsed 2x 3 min in the incubation buffer and 10 set in distilled water and then dried under a flow of air at room temperature.
Sections were then juxtaposed to X-OMAT-AR 
RESULTS
Regional and cellular distribution of the 5-HT,, receptor and its mRNA in control rats
Labeling with the 5-HT,, cRNA probe or with ['2'1]DOI exhibited a latero-medial gradient of distribution in the striatum of control rats (Fig. IA,@. Quantitative analysis of the film radioautographs demonstrated that the labeling with the 5-HT,, cRNA probe was higher (+33% on average) in the medial than in the lateral sectors of the striatum (0.048 t 0.002 vs 0.032 i 0.002; n = 6). Similarly, the level of ['*"I]DOI binding was higher (+43% on average) in the medial than in the lateral striatal sectors (0.136 t-0.023 vs 0.078 5 0.012; n = 6).
Observation of the emulsion radioautographs revealed the presence of neurons intensely labeled with the dark-blue alkalinephosphatase reaction product in the striatum. In contrast, no such labeling could be detected in the overlying cerebral cortex (not shown). In many instances, the digoxigenin-unlabeled neuronal profiles could be distinguished from the surrounding neuropil as light blue spots (see Fig. 5 ). In addition, the presence of silver grains accumulations on digoxigenin-unlabeled neurons allowed their unambiguous identification.
Neuronal profiles showing an accumulation of three or more silver grains were considered labeled with the S-HT,, cRNA probe.
Labeling with the 5-HT,, cRNA probe was visible in digoxigenin-labeled as well as in digoxigenin-unlabeled neurons. Comparison with adjacent Nissl-stained sections indicated that almost 90% of the striatal neurons in the medial and -70% of the striatal neurons in the lateral sector were labeled with the 5-HT,, cRNA probe (Table 1 ). The average numbers of neurons labeled with the S-HT,, cRNA probe (PPE-labeled and PPE-unlabeled) were slightly lower but not significantly different in the lateral than in the medial striatal sector (Table 1) . A large majority (over 95%) of PPE-labeled neurons exhibited 5-HT,, labeling in the lateral and medial striatal sectors. In both striatal sectors, a proportion of SO-60% of neurons expressing the 5-HT,, mRNA was also labeled with the PPE cRNA probe. As estimated from one representative control rat, the level of labeling with the 5-HT,, cRNA probe was higher in neurons of the ventromedial than in neurons of the ventrolateral striatal sector in both PPEunlabeled (+48%; 100.2 i 7.7 vs 67.9 5 4.2 pixels per neuron; n = 50) and PPE-labeled (+35%; 107.6 ? 8.4 vs 79.7 2 7.2 pixels per neuron; II = 50) neurons. Effect of neonatal 6-OHDA injections and administration of dopamine-receptor agonists on 5-HT,, mRNA levels
Brain sections from adult, sham-operated or 6-OHDA-lcsioned, rats were first processed for ['Hlmazindol binding to evaluate the loss of dopamine axon terminals in the striatum after neonatal 6-OHDA injections. Intense ['Hlmazindol labeling was observed in the striatum of sham-operated rats (Fig. 24) . In contrast, very weak labeling was observed in the striatum of rats injected with 6-OHDA as neonates and treated or not with apomorphine or SKF-38393 as adults (Figs. 2B, 3 ). In accordance with a previous report (Molina-Holgado et al., 1994) , the levels of ['Hlcitalopram binding to 5-HT reuptake sites were significantly increased in the striatum of rats injected with 6-OHDA as neonates (Fig. 2C,D) . Chronic administration of apomorphine or SKF-38393 to these rats did not affect the levels of [3H]citalopram binding that remained significantly higher than the levels measured in shamoperated rats (Fig. 3) .
The quantification of labeling with the 5-HT2, cRNA probe was performed on x-ray film radioautographs at two frontal levels of the striatum; that is, A = 10 and A = 9.2, according to the stereotaxic atlas of Paxinos and Watson (1986) . At the rostralmost level (A = lO.O), the ANOVAs demonstrated significant differences in 5-HT,, mRNA levels between the five experimental groups of rats in the dorsomedial (Fc4,23) = 7.4; p = 0.0006), the ventromedial (F(,,,,) = 6.6; p = O.OOll), the dorsolateral (Fc4,23) = 5.8, p = 0.0022), and the ventrolateral (Fcd,2.1) = 5.9, p = 0.0021) striatal sectors. At the caudal-most level (A = 9.2), the ANOVAs demonstrated significant differences in 5-HT,, mRNA levels between the five experimental groups in the dorsomedial (Fpwj = 8.6, p = 0.0002), the dorsolateral (Fc4,2sj = 8.5, p = 0.0002), the ventrolateral (Fc4,25j = 9.0, p = 0.0001) but not the ventromedial striatal sector. At the rostral-most level of the striatum, the average level of labeling with the 5-HT,, cRNA probe was significantly increased in the four striatal sectors of 6-OHDA-lesioned rats when compared to the labeling in sham-operated rats (Fig. 4A) . The increased labeling was more prominent in the lateral than in the medial striatal sectors (Fig. 4A) . At the caudal-most level of the striatum, the average 5-HT,, mRNA labeling was increased in the dorsolateral, the ventrolateral, and the dorsomedial sectors of June 1, 1996, 16(11) , and from adult rats injected with 6-OHDA as neonates and treated chronically with apomorphine (E, F) or SKF-38393 (G, H). The labeling intensity in each condition was measured by computerized densitometry in the four striatal sectors illustrated in Figure  1B . The surface of analysis shown for the dorsomedial sector was identical for the three other striatal sectors. 6-OHDA-lesioned rats (Fig. 4B) . At the two frontal levels examined, the labeling with the. 5-HT,, cRNA probe in 6-OHDAlesioned rats appeared homogeneously distributed over the whole striatal surface (Fig. 1C) . Chronic apomorphine or SW-38393 administration to adult rats lesioned with 6-OHDA as neonates abolished the increases in 5-HT,, mRNA levels in all, except the ventromedial, striatal sectors (Figs. lC,E,G, U,B). As a consequence, the striatum of rats lesioned with 6-OHDA as neonates and treated with apomorphine or SKF-38393 exhibited a pronounced latero-medial gradient of labeling with the 5-HT,, cRNA probe that resembled the gradient observed in shamoperated rats (Fig. l&G) . (Figs. 1D  4C ). In the medial striatal sectors, there were small increases in labeling that did not reach statistical significance (Fig. 4C) . As a result of the preferential increase in the lateral striatal sectors, ['251 ]DOI labeling in 6-OHDA-lesioned rats appeared homogeneously distributed over the whole striatal surface (Fig. 1D) . Chronic administration of apomorphine or SKF-38393 to 6-OHDA-lesioned rats abolished the increases in ['251]DOI binding levels in the dorsolateral and ventrolateral striatal sectors but did not produce any statistically significant effect in the dorsomedial or ventromedial striatal sectors (Figs. lD,F,H, 4C ). The selective effect of apomorphine and SKF-38393 in the lateral striatal sectors resulted in a pronounced latero-medial gradient of distribution of [1251]DOI labeling that resembled the distribution observed in sham-operated rats (Fig. lF,H) . The effects of SKF-38393 on striatal [1251]DOI levels were antagonized by the concomitant administration of SCH-23390 (Fig. 4C ).
Cellular distribution of the mRNA encoding for the 5-HT, receptor Analysis of the emulsion radioautographs indicated that, as in control rats, the 5-HT,, mRNA labeling in 6-OHDA-lesioned rats was distributed in PPE-labeled as well as in PPE-unlabeled neurons (Table 1 ). In addition, more than 95% of PPE-labeled neurons also expressed the 5-HT,, mRNA. In each experimental group, the numbers of neurons exclusively labeled with the radioactive 5-HT, cRNA probe or double-labeled with the 5-HT,, and the PPE cRNA probes were not significantly different in the (Table 1 ). In addition, the numbers of single-or double-labeled neurons in the medial striatum were not significantly different between experimental groups (Table 1 ). In the lateral striatal sector, however, the ANOVAs indicated a significant difference between experimental groups in the number of neurons expressing the 5-HT,, mRNA (Fc4,23j = 3.5; p = 0.0231) or expressing both the 5-HT,, and the PPE mRNAs (Fc4,23j = 4.6; p = 0.0073). Therefore, the numbers of neurons (labeled or not with the PPE cRNA probe) expressing the 5-HT,, mRNA were slightly higher in 6-OHDA-lesioned rats when compared to the sham-operated rats or when compared to the 6-OHDA-lesioned rats that were treated with apomorphine or SKF-38393 (Table 1 ). In contrast, the numbers of Nissl-stained neuronal profiles in all these groups were not significantly different (Table 1 ). This indicated that some striatal neurons in the lateral sector of control and 6-OHDA-lesioned rats treated with apomorphine or SKF-38393 did not express the 5-HT,, mRNA or were below the threshold of detection.
Quantification of 5-HT,, mRNA levels was then performed on emulsion radioautographs in individual neurons labeled or unlabeled with PPE in a ventrolateral striatal sector (Fig. 5) . The ANOVAs indicated significant differences between experimental groups in the number of pixels per neuron in PPE-unlabeled (Fc4,2,jj = 6.4, p = 0.0018) but not PPE-labeled (Fc4,2,jj = 0.406, p = 0.8020) striatal neurons (Fig. 6 ). Pairwise comparisons with sham-operated rats showed that the 5-HT, mRNA labeling in 6-OHDA-lesioned rats was significantly increased in PPE-unlabeled neurons (Figs. 5A,B, 6 ). This increase was abolished after apomorphine or SIG38393 administration (Figs. 5B-D, 6 ). The effect of SIG-38393 on 5-I-IT,, mRNA labeling in PPE-unlabeled neurons was blocked by concomitant administration of SCH-23390 (Fig. 6) . The histograms of frequency distribution of the 5-HT,, mRNA labeling in PPE-labeled and PPE-unlabeled neurons shown in Figure 7 illustrate the increase of 5-HT,, mRNA labeling in the population of PPE-unlabeled Figure 5. Bright-field photomicrographs of brain sections processed for in situ hybridization histochemistry with a 35S-labeled 5-HT,, cRNA probe and a digoxigenin-labeled PPE cRNA probe in a ventrolateral striatal sector. Labeling is from an adult control sham-operated rat (A), an adult rat lesioned with 6-OHDA as neonate (B), and an adult rat lesioned with 6-OHDA as neonate and chronically injected with apomorphine (C) or SW-38393 (0). Neurons labeled with the 5-HT,, cRNA probe are indicated by the UTYOWS. Note the increased labeling on the PPE-unlabeled neuron of the 6-OHDA-lesioned rat (B). Scale bar, 10 pm.
neurons in 6-OHDA-lesioned rats and its reversal after apomorphine or SKF-38393 administration.
DISCUSSION
Our results indicate that neonatal 6-OHDA lesions induce concomitant increases in the levels of serotonin 5-HT,, receptor and mRNA in the adult rat striatum. Such increases are abolished in the lateral sectors of the striatum after chronic and systemic administration of apomorphine or SKF-38393. The changes in mRNA levels encoding for the .5-HT,, receptor are restricted to a subpopulation of striatal neurons that do not express the PPE mRNA.
Distribution of the striatal 5-HT, receptor and its mRNA The distribution of labeling with the 5-HT,, cRNA probe in the striatum of control rats was similar to the distribution observed with ['2sI]DOI. In both cases, labeling was heterogeneous and was more intense in the medial sectors of the striatum. This similar distribution of labeling is a strong indication that the cRNA probe and [12sI]DOI specifically labeled the 5-HT, mRNA and receptor, respectively. This is consistent with previous reports showing that DO1 in presence of 30 nM 5-HT labels the 5-HT,, but not the closely related 5-HT,, (formerly 5-HT,,) receptor site (Mengod et al., 1990) . The comparable distribution of labeling with the cRNA probe and with [12sI]DOI also suggests that most striatal 5-HT,, receptors are distributed in cell bodies. This conclusion is consistent with previous reports (Fishette et al., 1988; Mengod et al., 1990; Pompeiano et al., 1994) . A proportion of striata15-HT,, receptors would also be localized on dopaminergic nerve terminals (Muramatsu et al., 1988) . However, this fraction of receptors was probably not detected in 6-OHDA-lesioned rats, and the changes in striatal ['2sI]DOI binding levels measured in these rats most likely reflect changes in the number of postsynaptic receptors. After neonatal 6-OHDA lesions, increased levels of the 5-HT,, receptor and mRNA were particularly prominent in the lateral striatal sectors. As a consequence, the heterogeneous distribution of labeling observed in control rats became rather homogeneous in 6-OHDA-lesioned rats. Chronic administration of apomorphine or SKI?-38393 resulted again in a pronounced latero-medial gradient of distribution of labeling. Cellular analysis indicated that this gradient was primarily attributable to higher 5-HT,, mRNA levels in neurons of the medial striatal sectors. Altogether, these results suggest that the heterogeneous distribution of the 5-HT,, receptor in the rat striatum is under the control of dopamine. In particular, dopamine appears to exert an inhibitory control on the expression of the 5-HT,, receptor and/or mRNA in neurons of the lateral striatum. At the caudal-most level examined, the correspondence between the levels of 5-HT2* mRNA and ['2sI]DOI binding was not observed in the dorsomedial sector of the striatum. In this sector, increased 5-HT, mRNA levels in 6-OHDA-lesioned rats were paralleled by a small but nonsignificant increase in ['*'I]DOI binding levels. In addition, administration of apomorphine or SKF-38393 abolished the increased levels of the S-HT,, mRNA, but it had no consistent effect on ['2'I]DOI binding levels. This suggests a certain degree of mismatch between the regulation of the mRNA and the receptor itself in this dorsomedial striatal sector.
Regulation of striatal 5-HT receptors by dopamine receptor agonists Administration of apomorphine or SKF-38393 had a comparable inhibitory effect on the levels of the striatal 5-HT,, receptor and its mRNA. Furthermore, the effect of SKF38393 was blocked by the preferential dopamine Dl receptor antagonist SCH-23390. These results strongly suggest that the effects of apomorphine and SKF-38393 are mediated by Dl receptors. In normal rats, systemic administration of apomorphine has been shown to induce an increase in the intracellular levels of 5-HT in the raphe dorsalis and a decrease in the extracellular concentration of 5-HT in the striatum (Lee and Geyer, 1992; FerrC et al., 1994) . The regulation of 5-HT levels by apomorphine is mediated by dopamine D2, but not Dl, receptors in the raphe dorsalis (Ferre and Artigas, 1993) . In addition, when directly infused into the striatum, apomorphine or SKF-38393 do not alter the extracellular concentration of serotonin (Fern? et al., 1994) . In light of these previous and our own results, it seems unlikely that the effects of apomorphine or SKF-38393 on the levels of the 5-HT,, receptor and its mRNA involve an action on striatal 5-HT neurons. This interpretation is also supported by the fact that apomorphine or SKF-38393 failed to alter the increases in citalopram binding levels measured in 6-OHDA-lesioned rats. Changes in 5-HT,, mRNA levels in 6-OHDA-lesioned rats were exclusively observed in the subpopulation of striatal neurons that do not express the PPE mRNA. It has been previously shown that the majority of striato-pallidal neurons contain the mRNA encoding for enkephalin whereas the majority of striato-nigral neurons express the mRNAs encoding for dynorphin and substance P, but not enkephalin (Gerfen et al., 1990; for review, see also Gerfen, 1992) . Thus, our results suggest that the 5-HT,, mRNA is expressed in both striato-pallidal and striato-nigral neurons but its regulation by dopamine receptors occurs only in striato-nigral neurons. Striato-nigral neurons have been shown to preferentially express the dopamine Dl receptor (Gerfen et al., 1990) whereas striato-pallidal neurons express the D2 receptor (Gerfen et al., 1990; Le Moine et al., 1990) . It can thus be speculated that Dl receptors are coupled to intracellular pathways that directly participate in the regulation of the 5-HT,, receptor and/or mRNA.
Functional consequences of SHT, receptor regulation
The increased number of 5-HT,, receptors after neonatal 6-OHDA injections may result in hypersensitive responses of striatal neurons to serotonin. This interpretation is supported by previous findings of increased responsiveness of striatal neurons to the inhibitory action of 5-HT or DOI (El Mansari et al., 1994) . Another study has shown, however, that 5-HT in such rats elicit excitations rather than inhibitions of striatal neurons (Luthman et al., 1993) . Eventual changes in the responsiveness of striatal neurons to 5-HT,, receptor agonists after neonatal 6-OHDA would be associated with an increase in evoked release of striatal 5-HT (Jackson and Abercrombie, 1992) without concomitant changes in the extracellular levels or basal release of 5-HT (Jackson and Abercrombie, 1992; Luthmann et al., 1993; MolinaHolgado et al., 1993 MolinaHolgado et al., , 1994 . After chronic administration of dopamine receptor agonists to rats lesioned with 6-OHDA as neonates, it can be expected that the hypersensitivity of striatal neurons to 5-HT receptor agonists will be reversed or attenuated as a consequence of decreased expression of the 5-HT,, receptor.
Previous reports have shown that systemic administration of DO1 to adult rats can induce an increase in striatal substance P mRNA and peptide levels (Walker et al., 1991) . In addition, lesions of 5-HT neurons with 5,7-dihydroxytryptamine result in a decrease in dynorphin levels without concomitant changes in the levels of striatal PPE mRNA (Morris et al., 1992) . On the other hand, a facilitator-y role of Dl receptor agonists on the levels of striatal dynorphin and substance P mRNAs has been documented previously (Gerfen et al., 1990) . Altogether, these studies indicate that dopamine through Dl receptors, and 5-HT through 5-HT,, receptors, exert a facilitatory control on the expression of peptides in striato-nigral neurons. It is therefore possible that the control of dopamine Dl receptors on the expression of serotonin 5-HTzA receptors has important consequences on the regulation of neurotransmitters in striato-nigral neurons. Adult rats injected with 6-OHDA as neonates do not exhibit the severe behavioral abnormalities observed when similar extensive lesions are performed on adults (Breese et al., 1984 , Bruno et al., 1987 Weihmuller and Bruno; 1989; Zigmond et al., 1990; Johnson and Bruno, 1992) . However, these rats exhibit some learning deficits as well as a motor hyperactivity and a behavioral hypersensitivity to the administration of dopamine Dl agonists (Erinoff et al., 1979; Heffner et Seiden, 1982; Breese et al., 1984 Breese et al., , 1985a Schallert et al., 1989; Gong et al., 1992 Gong et al., , 1993 . The motor hyperactivity can be reversed by the systemic administration of ketanserin or mianserin and therefore appears to be mediated by Number of pixels per neuron 5-HT,, receptors (Luthman et al., 1991) . Altered expression of SHT,, receptors in rats lesioned with 6-OHDA as neonates might thus play a critical role in the genesis and maintenance of this motor hyperactivity.
Conclusions
The major finding of the present study is that stimulation of dopamine Dl receptors inhibits the expression of SHT,, receptors in presumed striato-nigral neurons of the lateral striatum. In the rat striatum, the lateral regions are involved in sensorimotor functions (Dunnett and Iversen, 1981) . The control of serotonin SHT,, receptors by Dl receptors in the lateral striatum might thus represent an important mechanism involved in the regulation of sensorimotor and motor striatal functions. In keeping with evidence showing that 5-HT increases the release of dopamine in the striatum (Benloucif et al., 1993; Gallaway et al., 1993; Yadid et al., 1994; Bonhomme et al., 1995) , the negative control of dopamine receptors on the expression of 5-HT,, receptors can be viewed as a homeostatic mechanism aimed at balancing the effects of dopamine and 5-HT on motor activity. 
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